Liposome-based polymer complex as a novel adjuvant:Enhancement of specifc antibody production and isotype switch

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 607-621

  Chen, Chia Hung ^a   Lin, Yu Ling ^a   Liu, Yen Ku ^a   He, Pei Juin ^b   Lin, Ching Min ^a   Chiu, Yi Han ^b   Wu, Chang Jer ^c   Cheng, Tian Lu ^d   Liu, Shih Jen ^e,f   Liao, Kuang Wen ^a,b  

^a Institute of Molecular Medicine and Bioengineering   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adjuvant; Class switch; Immunomodulator; Liposome PEG PEI complex; Vaccine

Indexed keywords

ANTIGEN; BOVINE SERUM ALBUMIN; CELL SURFACE MARKER; CPG OLIGODEOXYNUCLEOTIDE; FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOLOGICAL ADJUVANT; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LIPOSOME POLYETHYLENE GLYCOL POLYETHYLENEIMINE COMPLEX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHAPERONIN 60; CYTOKINE; DRUG DERIVATIVE; IMMUNOGLOBULIN G; LEUKOCYTE ANTIGEN; LIPOSOME; MACROGOL DERIVATIVE; MEMBRANE PROTEIN; POLY(ETHYLENE GLYCOL) CO POLY(ETHYLENEIMINE); POLY(ETHYLENE GLYCOL)-CO-POLY(ETHYLENEIMINE); POLYETHYLENEIMINE; CD86 ANTIGEN; DRUG CARRIER; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; LIPOSOME POLYETHYLENE GLYCOL POLYETHYLENIMINE COMPLEX; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYMER;

ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PHAGOCYTE; PROTEIN EXPRESSION; SPLEEN CELL; SURFACE PROPERTY; TH1 CELL; TH2 CELL; VACCINATION; ANALYSIS OF VARIANCE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENE REARRANGEMENT; HUMAN; IMMUNOLOGY; METABOLISM; SPLEEN; T LYMPHOCYTE; ANTIGEN BINDING; ANTIGEN EXPRESSION; CYTOTOXICITY TEST; HUMORAL IMMUNITY; IMMUNOREGULATION; IMMUNOSTIMULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; SURFACE CHARGE;

ADJUVANTS, IMMUNOLOGIC; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINE; CHAPERONIN 60; CYTOKINES; FEMALE; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; LIPOSOMES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; PHAGOCYTES; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; SPLEEN; T-LYMPHOCYTES;

EID: 84863055513     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S28097     Document Type: Article

References (43)

1. Aguilar JC, Rodriguez EG. Vaccine adjuvants revisited. Vaccine. 2007;25(19):3752-3762.
2. Erikçi E, Gursel M, Gürsel I. Differential immune activation following encapsulation of immunostimulatory CpG oligodeoxynucleotide in nanoliposomes. Biomaterials. 2011;32(6):1715-1723.
3. Hafner AM, Corthésy B, Textor M, Merkle H P. Tuning the immune response of dendritic cells to surface-assembled poly(I:C) on micro-spheres through synergistic interactions between phagocytic and TLR3 signaling. Biomaterials. 2011;32(10):2651-2661.
4. Zhang Z, Tongchusak S, Mizukami Y, et al. Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery. Biomaterials. 2011;32(14):3666-3678.
5. Heffernan MJ, Zaharoff DA, Fallon JK, Schlom J, Greiner J W. In vivo effcacy of a chitosan/IL-12 adjuvant system for protein-based vaccines. Biomaterials. 2011;32(3):926-932.
6. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996;383(6603):787-793.
7. Hernández-Pando R, Orozcoe H, Sampieri A, et al. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology. 1996;89(1):26-33.
8. Bais AG, Beckmann I, Lindemans J, et al. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol. 2005;58(10): 1096-1100.
9. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8(3):223-246.
10. Stavnezer J. Immunoglobulin class switching. Curr Opin Immunol. 1996;8(2):199-205.
11. Singh VK, Mehrotra S, Agarwal SS. The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy. Immunol Res. 1999;20(2):147-161.
12. García BE, Sanz ML, Gato JJ, Fernández J, Oehling A. IgG4 blocking effect on the release of antigen-specifc histamine. J Investig Allergol Clin Immunol. 1993;3(1):26-33.
13. Parham P. The Immune System. 3rd ed. New York, NY: Garland Science; 2009.
14. Nordly P, Madsen HB, Nielsen HM, Foged C. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators. Expert Opin Drug Deliv. 2009;6(7):657-672.
15. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408(6813):740-745.
16. Park SR, Kim HA, Chun SK, Park JB, Kim PH. Mechanisms underlying the effects of LPS and activation-induced cytidine deaminase on IgA isotype expression. Mol Cells. 2005;19(3):445-451.
17. Kin NW, Chen Y, Stefanov EK, Gallo RL, Kearney JF. Cathelin-related antimicrobial peptide differentially regulates T- and B-cell function. Eur J Immunol. 2011;41(10):3006-3016.
18. Liou CJ, Tseng J. A Chinese herbal medicine, fu-ling, regulates interleukin-10 production by murine spleen cells. Am J Chin Med. 2002;30(4):551-560.
19. Liou CJ, Li ML, Tseng J. Intraperitoneal injection of ginseng extract enhances both immunoglobulin and cytokine production in mice. Am J Chin Med. 2004;32(1):75-88.
20. Liu YK, Lin YL, Chen CH, et al. A unique and potent protein binding nature of liposome containing polyethylenimine and polyethylene glycol: a nondisplaceable property. Biotechnol Bioeng. 2010;108(6):1318-1327.
21. Bennewitz NL, Babensee JE. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. Biomaterials. 2005;26(16):2991-2999.
22. Coombes AG, Major D, Wood JM, Hockley DJ, Minor PD, Davis SS. Resorbable lamellar particles of polylactide as adjuvants for infuenza virus vaccines. Biomaterials. 1998;19(11-12):1073-1081.
23. Matzelle MM, Babensee JE. Humoral immune responses to model antigen co-delivered with biomaterials used in tissue engineering. Biomaterials. 2004;25(2):295-304.
24. Ghendon Y, Markushin S, Akopova I, Koptiaeva I, Krivtsov G. Chitosan as an adjuvant for poliovaccine. J Med Virol. 2011;83(5):847-852.
25. Jiang HL, Kang ML, Quan JS, et al. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization. Biomaterials. 2008;29(12):1931-1939.
26. Kwong B, Liu H, Irvine DJ. Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy. Biomaterials. 2011;32(22):5134-5147.
27. Chhibber S, Wadhwa S, Yadav V. Protective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumonia. Jpn J Infect Dis. 2004;57(4):150-155.
28. van Slooten ML, Storm G, Zoephel A, et al. Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines. Pharm Res. 2000;17(1):42-48.
29. McGettrick AF, O'Neill LA. Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis. Br J Haematol. 2007; 139(2):185-193.
30. Rajput ZI, Hu SH, Xiao C W, Arijo AG. Adjuvant effects of saponins on animal immune responses. J Zhejiang Univ Sci B. 2007;8(3):153-161.
31. Lin YL, Liu YK, Tsai NM, et al. A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells. Nanomedicine. 2011. Epub June 24, 2011.
32. Chow YH, Chiang BL, Lee YL, et al. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol. 1998;160(3):1320-1329.
33. Suto A, Nakajima H, Hirose K, et al. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C(epsilon) transcription of IL-4-stimulated B cells. Blood. 2002;100(13):4565-4573.
34. Mueller C, Keeler A, Braag S, Menz T, Tang Q, Flotte TR. Modulation of Exaggerated-IgE Allergic Responses by Gene Transfer-mediated Antagonism of IL-13 and IL-17e. Mol Ther. 2010;18(3):511-518.
35. Regnström K, Ragnarsson EG, Köping-Höggård M, Torstensson E, Nyblom H, Artursson P. PEI - a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in mice. Gene Ther. 2003;10(18):1575-1583.
36. Korsholm KS, Agger EM, Foged C, et al. The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes. Immunology. 2007;121(2):216-226.
37. Christensen D, Agger EM, Andreasen LV, Kirby D, Andersen P, Perrie Y. Liposome-based cationic adjuvant formulations (CAF): past, present, and future. J Liposome Res. 2009;19(1):2-11.
38. Grommé M, Neefjes J. Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol Immunol. 2002;39(3-4):181-202.
39. Godbey WT, Wu KK, Mikos AG. Poly(ethylenimine) and its role in gene delivery. J Control Release 1999;60(2-3):149-160.
40. Akinc A, Thomas M, Klibanov AM, Langer R. Exploring polye thylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med. 2005;7(5):657-663.
41. Chen J, Li Z, Huang H, et al. Improved antigen cross-presentation by polyethyleneimine-based nanoparticles. Int J Nanomedicine. 2011;6:77-84.
42. Kitazoe M, Murata H, Futami J, et al. Protein transduction assisted by polyethylenimine-cationized carrier proteins. J Biochem. 2005; 137(6):693-701.
43. Didenko V V, Ngo H, Baskin DS. Polyethyleneimine as a transmem-brane carrier of fuorescently labeled proteins and antibodies. Anal Biochem. 2005;344(2):168-173.